1. Pink Sheet
  2. >>R&D
  3. >>Clinical Trials

Adolescent Recruitment For COVID-19 Vaccine Trials Is Worry For Operation Warp Speed

 
• By Derrick Gingery

However, recruitment for adult trials remains robust, OWS’ Slaoui says.

Alex Azar stands at OWS briefing on 12 January 2021 (screenshot)
HHS Secretary Alex Azar speaks at likely his last Operation Warp Speed briefing on 12 January. • Source: Screenshot

Adult coronavirus vaccine clinical trial enrollment may continue moving at a brisk pace, but pediatric trials are recruiting more slowly, which could delay indication expansion.

The search for pediatric patients concerns Moncef Slaoui, Operation Warp Speed chief scientific advisor. During a 12 January OWS briefing, Slaoui said that Moderna, Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D

Unlocking Opportunities: How To Engage With The EMA On Animal Testing Alternatives

 
• By Neena Brizmohun

The European Medicines Agency, like its counterpart in the US, is increasingly focusing on the use of alternatives to animal testing.

EU Pharma Reform: Exclusivity Vouchers Alone Are Insufficient Incentive For Antimicrobials, Industry Says

 
• By Eliza Slawther

European pharma trade associations EFPIA and EUCOPE outline their respective views on how the EU’s pharma legislation overhaul should tackle antimicrobial resistance, and why transferable exclusivity vouchers alone will not suffice as incentives.

What The EMA Can Teach HTA Bodies About Joint Clinical Assessments

 
• By Francesca Bruce

EU-level joint clinical assessments conducted under the Health Technology Assessment Regulation need to be more flexible when it comes to evidence requirements, according to experts speaking at a gene and cell therapy conference.